Skip to main content
Fig. 2 | Infectious Agents and Cancer

Fig. 2

From: Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma

Fig. 2

The prognostic predictive value of PAR2 in HCC. Kaplan-Meier survival analysis showed that HCC patients with high expression of PAR2 had a worse prognosis in overall survival than patients with low expression of PAR2 (P = 0.033, a). For disease-free survival, patients with low expression of PAR2 had a better prognosis in disease-free survival compared with patients with high expression of PAR2 (P = 0.043, b). For HCC recurrence, significantly higher proportion of recurrence in patients with high expression level of PAR2 compared with low expression group (P = 0.047, c)

Back to article page